These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7735367)

  • 1. Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group.
    Lanes R; Carrillo E
    J Pediatr Endocrinol; 1994; 7(4):303-8. PubMed ID: 7735367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
    Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with growth hormone-releasing hormone (GHRH) 1-44 in children with idiopathic growth hormone deficiency: a randomized double-blind dose-effect study. The GHRH European Multicenter Study (GEMS) Group.
    Lievre M; Chatelain P; Van Vliet G; Olivier M; Blanchard J; Morre M; Boissel JP
    Fundam Clin Pharmacol; 1992; 6(8-9):359-66. PubMed ID: 1292967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
    Ross RJ; Rodda C; Tsagarakis S; Davies PS; Grossman A; Rees LH; Preece MA; Savage MO; Besser GM
    Lancet; 1987 Jan; 1(8523):5-8. PubMed ID: 2879138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of beta 1-adrenergic blockade on the growth response to growth hormone (GH)-releasing hormone therapy in GH-deficient children.
    Cassorla F; Mericq V; García H; Cristiano A; Avila A; Boric A; Iñiguez G; Merriam GR
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2997-3001. PubMed ID: 7559887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone-releasing hormone reverses secondary somatotroph unresponsiveness.
    Romer TE; Rymkiewicz-Kluczynska B; Olivier M; Sagnard L; Szarras-Czapnik M
    J Clin Endocrinol Metab; 1991 Feb; 72(2):503-6. PubMed ID: 1991817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
    Thorner MO; Rogol AD; Blizzard RM; Klingensmith GJ; Najjar J; Misra R; Burr I; Chao G; Martha P; Mcdonald J
    Pediatr Res; 1988 Aug; 24(2):145-51. PubMed ID: 3141891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.
    Thorner M; Rochiccioli P; Colle M; Lanes R; Grunt J; Galazka A; Landy H; Eengrand P; Shah S
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1189-96. PubMed ID: 8772599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
    Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
    J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.
    Neyzi O; Yordam N; Ocal G; Bundak R; Darendeliler F; Açikgöz E; Berberoğlu M; Günöz H; Saka N; Calikoğlu AS
    Acta Paediatr Suppl; 1993 Mar; 388():16-21; discussion 22. PubMed ID: 8329826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
    Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency.
    Smith PJ; Brook CG; Rivier J; Vale W; Thorner MO
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):35-44. PubMed ID: 3098459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency?
    Smith PJ; Brook CG
    Arch Dis Child; 1988 Jun; 63(6):629-34. PubMed ID: 2898924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment with GHRH [1-44] amide in prepubertal children with classical growth hormone deficiency.
    Duck SC; Rapaport R
    J Pediatr Endocrinol Metab; 1999; 12(4):531-6. PubMed ID: 10417969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
    Hernández M; Fragoso J; Barrio R; Argente J; Arilla E
    Horm Res; 1988; 30(6):252-7. PubMed ID: 2907992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity.
    Kirk JM; Trainer PJ; Majrowski WH; Murphy J; Savage MO; Besser GM
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):487-93. PubMed ID: 7955460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nightly clonidine administration on growth velocity in short children without growth hormone deficiency: a double-blind, placebo-controlled study.
    Allen DB
    J Pediatr; 1993 Jan; 122(1):32-6. PubMed ID: 8419612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.